Speaking at an Analytical Cannabis webinar back in December 2020, Chris Tasker, CEO of Global Cannabinoid Solutions explored cannabidiol (CBD).
CBD is just the tip of the industrial iceberg. Making up just a fraction of cannabis’ potential, huge opportunities have been overlooked and new trends yet to be established. In the first of this three-part series, we will discuss the truth on CBD and see what the science really says about its potential risks and benefits. Explore the realms of scientific possibility and see what lays beyond the CBD trend.
During this webinar, Chris explored:
- Current scientific knowledge on CBD
- The overall risks and benefits of CBD
- The future of CBD science
More Information
Advertisement
Advertisement
